Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a research report report published on Saturday morning. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of Avinger stock opened at $0.47 on Friday. The stock has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.09. Avinger has a 12 month low of $0.36 and a 12 month high of $4.15. The business has a fifty day simple moving average of $0.48 and a 200 day simple moving average of $0.66.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.